Elfaky, M.A.; Thabit, A.K.; Sirwi, A.; Fahmy, U.A.; Bahabri, R.M.; Al-Awad, E.A.; Basaeed, L.F.
Development of a Novel Pharmaceutical Formula of Nanoparticle Lipid Carriers of Gentamicin/α-Tocopherol and In Vivo Assessment of the Antioxidant Protective Effect of α-Tocopherol in Gentamicin-Induced Nephrotoxicity. Antibiotics 2019, 8, 234.
https://doi.org/10.3390/antibiotics8040234
AMA Style
Elfaky MA, Thabit AK, Sirwi A, Fahmy UA, Bahabri RM, Al-Awad EA, Basaeed LF.
Development of a Novel Pharmaceutical Formula of Nanoparticle Lipid Carriers of Gentamicin/α-Tocopherol and In Vivo Assessment of the Antioxidant Protective Effect of α-Tocopherol in Gentamicin-Induced Nephrotoxicity. Antibiotics. 2019; 8(4):234.
https://doi.org/10.3390/antibiotics8040234
Chicago/Turabian Style
Elfaky, Mahmoud A., Abrar K. Thabit, Alaa Sirwi, Usama A. Fahmy, Raghdah M. Bahabri, Eman A. Al-Awad, and Lamis F. Basaeed.
2019. "Development of a Novel Pharmaceutical Formula of Nanoparticle Lipid Carriers of Gentamicin/α-Tocopherol and In Vivo Assessment of the Antioxidant Protective Effect of α-Tocopherol in Gentamicin-Induced Nephrotoxicity" Antibiotics 8, no. 4: 234.
https://doi.org/10.3390/antibiotics8040234
APA Style
Elfaky, M. A., Thabit, A. K., Sirwi, A., Fahmy, U. A., Bahabri, R. M., Al-Awad, E. A., & Basaeed, L. F.
(2019). Development of a Novel Pharmaceutical Formula of Nanoparticle Lipid Carriers of Gentamicin/α-Tocopherol and In Vivo Assessment of the Antioxidant Protective Effect of α-Tocopherol in Gentamicin-Induced Nephrotoxicity. Antibiotics, 8(4), 234.
https://doi.org/10.3390/antibiotics8040234
